Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Crystallogr E Crystallogr Commun ; 79(Pt 7): 596-599, 2023 Jun 01.
Article in English | MEDLINE | ID: mdl-37601577

ABSTRACT

The title copper(II) complex, [Cu(C16H13NO4)(C3H4N2)], consists of a tridentate ligand synthesized from l-tyrosine and salicyl-aldehyde. One imidazole mol-ecule is additionally coordinating to the copper(II) ion. The crystal structure features N-H⋯O, O-H⋯O and C-H⋯O hydrogen bonds. The Hirshfeld surface analysis indicates that the most important contributions to the packing are from H⋯H (37.9%), C⋯H (28.2%) and O⋯H/H⋯O (21.2%) contacts.

2.
Acta Crystallogr E Crystallogr Commun ; 79(Pt 4): 361-366, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-37057011

ABSTRACT

The mol-ecular structure of the title compound, [Cu(C12H13N2O3)(H2O)2]·[Cu(C12H13N2O3)(H2O)], consists of two different mol-ecules in the asymmetric unit. Both of the structures consist of a tridentate ligand synthesized from l-valine and salicyl-aldehyde, and one water mol-ecule or two water mol-ecules coordinating to CuII. They have a square-planar (mol-ecule 1) or a square-pyramidal (mol-ecule 2) coordination geometry. In the crystal, the mol-ecules form intra- and inter-molecular O-H⋯O hydrogen bonds involving the coordinated water mol-ecules and other sites. A Hirshfeld surface analysis indicated that the most important contributions to the packing are from H⋯H [52.9% (mol-ecule 1) and 51.1% (mol-ecule 2)] and H⋯O/ O⋯H [21.2% (mol-ecule 1) and 25.8% (mol-ecule 2)] contacts. In addition, an electrostatic potential map was also obtained from DFT calculations to support the discussion of the inter-molecular inter-actions.

3.
Front Chem ; 11: 1330833, 2023.
Article in English | MEDLINE | ID: mdl-38304569

ABSTRACT

We prepared L-amino acids (L-valine and L-serine, respectively) based on the Schiff base Cu2+ complexes CuSV and CuSS in the absence/presence of hydroxyl groups and their imidazole-bound compounds CuSV-Imi and CuSS-Imi to reveal the effects of hydroxyl groups on SOD activity. The structural and spectroscopic features of the Cu2+ complexes were evaluated using X-ray crystallography, UV-vis spectroscopy, and EPR spectroscopy. The spectroscopic behavior upon addition of lysozyme indicated that both CuSV and CuSS were coordinated by the imidazole group of His15 in lysozyme at their equatorial position, leading to the formation of hybrid proteins with lysozyme. CuSS-Imi showed a higher SOD activity than CuSV-Imi, indicating that the hydroxyl group of CuSS-Imi played an important role in the disproportionation of O2 - ion. Hybridization of the Cu2+ complexes CuSV and CuSS with lysozyme resulted in higher SOD activity than that of CuSV-Imi and CuSS-Imi. The improvements in SOD activity suggest that there are cooperative effects between Cu2+ complexes and lysozyme.

4.
J Med Virol ; 82(1): 128-37, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19950232

ABSTRACT

The identification of a safe and effective adjuvant that is able to enhance mucosal immune responses is necessary for the development of an efficient inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of extracts of mycelia derived from edible mushrooms as adjuvants for intranasal influenza vaccine. The adjuvant effect of extracts of mycelia was examined by intranasal co-administration of the extracts and inactivated A/PR8 (H1N1) influenza virus hemagglutinin (HA) vaccine in BALB/c mice. The inactivated vaccine in combination with mycelial extracts induced a high anti-A/PR8 HA-specific IgA and IgG response in nasal washings and serum, respectively. Virus-specific cytotoxic T-lymphocyte responses were also induced by administration of the vaccine with extract of mycelia, resulting in protection against lethal lung infection with influenza virus A/PR8. In addition, intranasal administration of NIBRG14 vaccine derived from the influenza A/Vietnam/1194/2004 (H5N1) virus strain administered in conjunction with mycelial extracts from Phellinus linteus conferred cross-protection against heterologous influenza A/Indonesia/6/2005 virus challenge in the nasal infection model. In addition, mycelial extracts induced proinflammatory cytokines and CD40 expression in bone marrow-derived dendritic cells. These results suggest that mycelial extract-adjuvanted vaccines can confer cross-protection against variant H5N1 influenza viruses. The use of extracts of mycelia derived from edible mushrooms is proposed as a new safe and effective mucosal adjuvant for use for nasal vaccination against influenza virus infection.


Subject(s)
Adjuvants, Immunologic , Agaricales , Hemagglutinin Glycoproteins, Influenza Virus , Influenza A Virus, H5N1 Subtype/pathogenicity , Influenza Vaccines , Mycelium , Orthomyxoviridae Infections , Vaccines, Inactivated , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Agaricales/growth & development , Agaricales/immunology , Animals , Antibodies, Viral/blood , Cross Reactions/drug effects , Cross Reactions/immunology , Hemagglutinin Glycoproteins, Influenza Virus/administration & dosage , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Humans , Immunity/drug effects , Immunity/immunology , Immunity, Mucosal , Immunoglobulin A, Secretory/metabolism , Immunoglobulin G/blood , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H1N1 Subtype/metabolism , Influenza A Virus, H5N1 Subtype/immunology , Influenza Vaccines/administration & dosage , Influenza Vaccines/immunology , Mice , Mice, Inbred BALB C , Mycelium/immunology , Orthomyxoviridae Infections/immunology , Orthomyxoviridae Infections/mortality , Orthomyxoviridae Infections/prevention & control , Orthomyxoviridae Infections/virology , T-Lymphocytes/immunology , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/immunology
5.
Evid Based Complement Alternat Med ; 2(3): 369-74, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16136215

ABSTRACT

Phellinus linteus, a mushroom, contains constituents that exhibit potent antitumor effects through activating immune cells. Recently, anti-inflammatory and anti-allergic properties of P. linteus extracts have also been implicated. In the present study, therefore, we separated the constituents of mycelium of P. linteus into five fractions-chloroform-soluble (CF), ethyl acetate-soluble (EA), methanol-soluble (AE), water-soluble (WA) and boiling water-soluble (BW) fractions-and examined their suppressive effects on the IgE-dependent mouse triphasic cutaneous reaction. The triphasic reaction was induced in the ear of BALB/c mice passively sensitized with anti-dinitrophenol IgE by painting with 2,4-dinitrofluorobenzene 24 h later. Ear swelling appeared triphasically with peak responses at 1 h, 24 h and 8 days after the challenge. ME, WA and BW given orally at a dose of 100 mg kg significantly inhibited the first and second phase ear swelling, and BW also inhibited the third phase response. CF only inhibited the second phase. The inhibition by BW was the most potent and almost dose-dependent at doses of 30-300 mg kg. BW also inhibited vascular permeability increase caused by passive cutaneous anaphylaxis and histamine, and ear swelling caused by tumor necrosis factor-alpha. In contrast, BW apparently potentiated the production of interleukin-4 and interferon-gamma from anti-CD3-stimulated mouse splenocytes. These results indicate that BW derived from mycelium of P. linteus contains some constituents with anti-allergic as well as immunopotentiating properties.

6.
Biosci Biotechnol Biochem ; 68(11): 2405-7, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15564685

ABSTRACT

Mycelial growth of the Matsutake mushroom (Tricholama matsutake) was much slower than that of the other mushroom species. We found that the addition of D-isoleucine to the culture medium strikingly promoted mycelia growth. The other amino acids tested had no effect on this growth promotion.


Subject(s)
Agaricales/drug effects , Agaricales/growth & development , Isoleucine/pharmacology , Mycelium/drug effects , Mycelium/growth & development , Culture Media , Dose-Response Relationship, Drug , Stimulation, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...